The rapid global adoption of GLP-1 weight-loss drugs such as Wegovy and Zepbound is triggering an unprecedented surge in demand for protein-rich whey ingredients, creating major shifts across the global dairy industry. According to a Reuters report, dairy companies and food manufacturers are investing heavily in whey protein production as consumers using obesity drugs increasingly seek high-protein diets to preserve muscle mass during weight loss. Industry executives and analysts stated that the trend is accelerating demand for whey protein concentrates and isolates used in protein shakes, nutritional beverages, yogurts, bars, and functional foods.
Data from consultancy StoneX showed that whey protein concentrate containing 80% protein (WPC 80) has risen nearly 90% over the past year to around €20,000 ($23,410) per metric ton, significantly outperforming other dairy commodities such as cheese and milk powder. Reuters noted that whey prices have surged more than 100% by 2026, even as cheese markets weakened, highlighting a major divergence inside the dairy value chain. Industry participants identified GLP-1-related nutrition demand as a key driver behind the whey market rally, alongside broader trends linked to healthy ageing and fitness-focused consumption.
Major dairy ingredient suppliers are now expanding production capacity and exploring new whey supply opportunities to address tightening availability. Luis Cubel, Managing Director at, stated that ongoing strong demand for whey proteins, increasingly fueled by GLP-1 drugs, is forcing the industry to assess whether additional untapped whey volumes can be developed. The trend is reshaping product development strategies as food companies reformulate products to include higher protein levels aimed at weight-management consumers.
The obesity-drug market itself is expanding rapidly, with analysts estimating the sector could exceed $120–150 billion annually by 2030 as more injectable and oral therapies enter global markets. Reuters reported that the launch of oral weight-loss pills by companies such as and is expected to further broaden consumer adoption, potentially increasing long-term demand for protein-enriched dairy ingredients. The growing overlap between pharmaceuticals, functional nutrition, and dairy ingredients is increasingly positioning whey protein as one of the dairy sector’s highest-value growth categories.
Industry observers believe the whey market boom could reshape global dairy economics by shifting more value toward protein extraction and functional nutrition applications rather than traditional commodity dairy products. Analysts also noted that whey, once treated largely as a by-product of cheese manufacturing, is rapidly emerging as a strategic dairy ingredient tied directly to the future growth of the global health and wellness economy.
Source: Dairynews7x7 8 May, 2025 Read full story here
#WheyProtein #GLP1 #FunctionalNutrition #DairyIngredients #ProteinMarket #GlobalDairy #DairyIndustry
